HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arianna Palladini Selected Research

Osteosarcoma (Osteogenic Sarcoma)

1/2019Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arianna Palladini Research Topics

Disease

28Neoplasms (Cancer)
08/2023 - 04/2005
9Breast Neoplasms (Breast Cancer)
08/2023 - 08/2007
9Carcinoma (Carcinomatosis)
10/2022 - 04/2005
7Neoplasm Metastasis (Metastasis)
11/2022 - 08/2007
7Rhabdomyosarcoma
01/2021 - 03/2006
7Carcinogenesis
04/2019 - 04/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 10/2020
2Sarcoma (Soft Tissue Sarcoma)
02/2010 - 03/2006
1Papillomavirus Infections
08/2023
1Hypoxia (Hypoxemia)
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2019
1Ewing Sarcoma (Sarcoma, Ewing)
01/2019
1Hepatitis B
01/2018
1Papilloma (Papillomatosis)
01/2018
1Noncommunicable Diseases
01/2018
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2018

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
08/2023 - 04/2005
7AntibodiesIBA
10/2022 - 04/2005
4Monoclonal AntibodiesIBA
10/2022 - 11/2007
4Insulin-Like PeptidesIBA
04/2019 - 02/2010
4Interleukin-12 (IL 12)IBA
01/2018 - 04/2005
3Cancer VaccinesIBA
08/2023 - 11/2007
3Immune Checkpoint InhibitorsIBA
11/2022 - 10/2020
3Trastuzumab (Herceptin)FDA Link
10/2022 - 11/2014
2LigandsIBA
10/2020 - 08/2007
2DNA (Deoxyribonucleic Acid)IBA
04/2019 - 01/2014
2Oncogene Proteins (Oncogene Protein)IBA
08/2017 - 01/2013
2Protein Isoforms (Isoforms)IBA
08/2017 - 11/2014
2AntigensIBA
06/2011 - 07/2007
2Interferon-gamma (Interferon, gamma)IBA
03/2009 - 04/2005
1Drug CombinationsIBA
01/2023
1Tyrosine Kinase InhibitorsIBA
11/2022
1CrizotinibIBA
11/2022
1Virus-Like Particle VaccinesIBA
10/2022
1ErbB Receptors (EGF Receptor)IBA
03/2022
1Sunitinib (Sutent)FDA Link
11/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1ClaudinsIBA
11/2021
1EnzymesIBA
01/2021
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2021
1InflammasomesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1InterferonsIBA
10/2020
1Sirolimus (Rapamycin)FDA Link
10/2020
1Mitogen-Activated Protein KinasesIBA
10/2020
1tyrosine receptor (receptor, tyrosine)IBA
04/2019
1Phosphotransferases (Kinase)IBA
04/2019
1human ERBB2 proteinIBA
04/2019
1Neutralizing AntibodiesIBA
02/2019
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019
1Caveolin 1IBA
01/2019
1CarcinogensIBA
01/2018
1Histocompatibility Antigens (Histocompatibility Antigen)IBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017
1PerforinIBA
05/2015
1Interleukin-15 (Interleukin 15)IBA
05/2015
1DNA VaccinesIBA
01/2014
1NVP-BKM120IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
11/2010
1ErbB-2 ReceptorIBA
11/2010
1ProteomeIBA
11/2010
1AutoantibodiesIBA
11/2010
1dactolisibIBA
02/2010
1Interleukin-4 (Interleukin 4)IBA
04/2009
1Myosins (Myosin)IBA
04/2009
1MyogeninIBA
04/2009
1TamoxifenFDA LinkGeneric
03/2009
1Histocompatibility Antigens Class IIBA
11/2007
1InterleukinsIBA
11/2007
1Chemokine ReceptorsIBA
08/2007
1Combined VaccinesIBA
07/2007
1Tumor Viral Antigens (Large T Antigen)IBA
07/2007
1Messenger RNA (mRNA)IBA
01/2007
1Connective Tissue Growth FactorIBA
01/2007
1Endothelin-3 (Endothelin 3)IBA
03/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2006
1Peptides (Polypeptides)IBA
03/2006
1ChemokinesIBA
04/2005

Therapy/Procedure

10Therapeutics
10/2022 - 11/2007
3Immunotherapy
08/2023 - 10/2020
1Aftercare (After-Treatment)
01/2021
1Intravenous Injections
02/2019